News
For now, however, the Prevnar brand remains largely unscathed ... "Despite the availability of current pneumococcal conjugate vaccines, many adults remain vulnerable to pneumococcal disease ...
The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...
Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides ...
Pneumococcal conjugate vaccines, including more than seven serotypes, will have potential for a larger effect than PCV7 in many countries, including Norway. A 13-valent pneumococcal conjugate ...
Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
The updated recommendations are pending final approval by the director of the CDC and the Department of Health and Human Services.
Applied in a vaccination program, the 7-valent pneumococcal conjugate vaccine (PCV7) in a 2+1 dose schedule appears to be highly effective. Conjugate vaccines with more than seven serotypes will ...
The pneumococcal conjugate vaccine – codenamed PCV21/GBP410 – has started pivotal trials in the prevention of both paediatric Streptococcus pneumoniae, which remains a major public health ...
Optiemus Electronics Ltd. to manufacture its next-generation AIoT products in India, in a significant step towards ...
Today, i.e. April 16, 2025, Luharuka Media & Infra Limited has inaugurated it's Third Branch Office and commenced its ...
5d
Pharmaceutical Technology on MSNACIP recommends GSK’s RSV vaccine for at-risk adults 50 to 59The recommendation builds on the committee’s June 2024 vote for the use of RSV vaccines for people aged 60 to 74 at high risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results